Biofourmis

Biofourmis is a biotechnology company based in Boston, Massachusetts, founded in 2015. It specializes in personalized care and therapies through the use of digital therapeutics. The company develops and delivers clinically validated software-based therapeutics that enhance patient outcomes. Biofourmis has created a predictive health analytics platform that analyzes physiology data gathered from clinical-grade wearables. Utilizing artificial intelligence, this platform integrates and interprets continuous physiological data to identify personalized patterns and predict potential clinical exacerbations. By enabling medical professionals to intervene days before critical events occur, Biofourmis aims to improve patient care and provide cost-effective solutions for healthcare providers.

Omar Ishrak Ph.D

Chairman

2 past transactions

Gaido

Acquisition in 2020
Gaido Health is an AI-driven platform focused on the continuous monitoring of post-discharge oncology patients. The company develops a remote monitoring system designed to enhance the quality of care and patient outcomes. Utilizing proprietary machine learning algorithms, Gaido's platform continuously tracks patient health, allowing for the early detection of deterioration. This proactive approach enables clinicians to quickly triage patients and effectively follow up with those at the highest risk, thereby improving overall patient management and care.

Biovotion

Acquisition in 2019
Biovotion AG, based in Zurich, Switzerland, is a medical device company specializing in continuous and non-invasive physiological and metabolic monitoring. The company has developed a wearable sensing technology, known as the Vital Sign Monitor, which enables accurate medical-quality vital sign monitoring in everyday life. This mobile device measures various parameters, including heart rate, blood oxygenation, blood perfusion, temperature, movement, and, in future iterations, heart rate variability, respiratory rate, energy expenditure, and stress levels. Biovotion's platform integrates a multi-sensor approach with sophisticated algorithms and cloud infrastructure, providing users with data comparable to traditional hospital systems. In addition to its product development, Biovotion offers consulting services in technical due diligence, clinical strategies, intellectual property, and quality management. As of November 2019, Biovotion operates as a subsidiary of Biofourmis Singapore Pte. Ltd.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.